Inhibition of miRNA‑21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN

Li,Chen; Xu,Binwu; Miu,Xinxin; Deng,Zhongbo; Liao,Hang; Hao,Liang

doi:10.3892/etm.2017.5477

Inhibition of miRNA‑21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN

Authors:
- Chen Li
- Binwu Xu
- Xinxin Miu
- Zhongbo Deng
- Hang Liao
- Liang Hao
View Affiliations

Affiliations: Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: November 10, 2017 https://doi.org/10.3892/etm.2017.5477
Pages: 1036-1040

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression of micro (mi)RNA‑21 in osteosarcoma cells, and its role in inhibiting the invasion and metastasis of osteosarcoma. Human osteosarcoma MG‑63 cells and osteoblast hFOB1.19 cells were used to compare the expression of miRNA‑21 using reverse transcription‑quantitative polymerase chain reaction analysis. A miRNA‑21 mimic or inhibitor were transfected into the MG‑63 cells to upregulate and downregulate the expression of miRNA‑21, respectively. The present study investigated the proliferation and invasion of transfected MG‑63 cells using MTT and Transwell assays. Western blot analyses were used to investigate the regulation of important proteins in the phosphatase and tensin homolog/phosphoinositide 3‑kinase/RAC‑α serine/threonine‑protein kinase (PTEN/PI3K/AKT) signaling pathway. Compared with hFOB1.19 cells, miRNA‑21 expression was significantly upregulated in the MG‑63 cells (P<0.01), which lead to increased proliferation. Downregulating miRNA‑21 expression reduced the proliferation of MG‑63 cells compared with hFOB1.19 cells. Invasion assays and western blot analyses revealed that the overexpression of miRNA‑21 significantly enhanced the invasion ability of MG‑63 cells and the expression of phosphorylated (p‑)AKT, while downregulation of miRNA‑21 expression reduced the protein level of AKT and p‑AKT. In the MG‑63 cells, miRNA‑21 upregulation significantly inhibited the protein level of PTEN, resulting in significantly increased AKT and PI3K protein levels (P<0.01). In conclusion, the results of the present study indicate that the expression of miRNA‑21, PI3K and AKT is increased in the osteosarcoma cell line MG‑63, which results in reduced expression of PTEN and increased expression of proteins in the PI3K/AKT signaling pathway, and thus increases the aggressiveness of osteosarcoma cells.

View Figures

View References

1	Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler PJ and Bruland ØS: Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncol. 54:25–33. 2015. View Article : Google Scholar : PubMed/NCBI
2	Ziyan W and Yang L: MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line. Ir J Med Sci. 185:85–91. 2016. View Article : Google Scholar : PubMed/NCBI
3	Venkatramani R, Murray J, Helman L, Meyer W, Hicks MJ, Krance R, Lau C, Jo E and Chintagumpala M: Risk-Based therapy for localized osteosarcoma. Pediatr Blood Cancer. 63:412–417. 2016. View Article : Google Scholar : PubMed/NCBI
4	Nakanishi A, Kitagishi Y, Ogura Y and Matsuda S: The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review). Int J Oncol. 44:1813–1819. 2014. View Article : Google Scholar : PubMed/NCBI
5	Rizvi MM, Alam MS, Mehdi SJ, Ali A and Batra S: Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population. Pathol Oncol Res. 18:309–313. 2012. View Article : Google Scholar : PubMed/NCBI
6	Wu YR, Qi HJ, Deng DF, Luo YY and Yang SL: MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol. 37:12061–12070. 2016. View Article : Google Scholar : PubMed/NCBI
7	Xue R, Lei S, Xia ZY, Wu Y, Meng Q, Zhan L, Su W, Liu H, Xu J, Liu Z, et al: Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: Role of the PI3K/Akt and JAK2/STAT3 pathways. Clin Sci (Lond). 130:377–392. 2016. View Article : Google Scholar : PubMed/NCBI
8	Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
9	Zhu L, Liu J and Cheng G: Role of miRNAs in schistosomes and schistosomiasis. Front Cell Infect Microbiol. 4:1652014. View Article : Google Scholar : PubMed/NCBI
10	Lee RC, Feinbaum RL and Ambros V: The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
11	Lu X, Fan Q, Xu L, Li L, Yue Y, Xu Y, Su Y, Zhang D and Wang L: Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression. PLoS One. 10:e01174002015. View Article : Google Scholar : PubMed/NCBI
12	Liu X, Luo F, Ling M, Lu L, Shi L, Lu X, Xu H, Chen C, Yang Q, Xue J, et al: MicroRNA-21 activation of ERK signaling via PTEN is involved in arsenite-induced autophagy in human hepatic L-02 cells. Toxicol Lett. 252:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Feng Y, Fan Y, Huiqing C, Zicai L and Quan D: The emerging landscape of long non-coding RNAs. Yi Chuan. 36:456–468. 2014.(In Chinese). PubMed/NCBI
15	Wagner A, Mayr C, Bach D, Illig R, Plaetzer K, Berr F, Pichler M, Neureiter D and Kiesslich T: MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines. Int J Mol Sci. 15:20134–20157. 2014. View Article : Google Scholar : PubMed/NCBI
16	Liu L, Chen L, Xu Y, Li R and Du X: microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun. 400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
17	Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34(Database Issue): D140–D44. 2006. View Article : Google Scholar : PubMed/NCBI
18	Anderson ME: Update on survival in osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
19	Gildea JJ, Herlevsen M, Harding MA, Gulding KM, Moskaluk CA, Frierson HF and Theodorescu D: PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene. 23:6788–6797. 2004. View Article : Google Scholar : PubMed/NCBI
20	Chu EC and Tarnawski AS: PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit. 10:RA235–RA241. 2004.PubMed/NCBI
21	Maehama T, Okahara F and Kanaho Y: The tumour suppressor PTEN: Involvement of a tumour suppressor candidate protein in PTEN turnover. Biochem Soc Trans. 32:343–347. 2004. View Article : Google Scholar : PubMed/NCBI
22	Levine RA, Forest T and Smith C: Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors. Vet Pathol. 39:372–378. 2002. View Article : Google Scholar : PubMed/NCBI
23	Wu ZH, Tao ZH, Zhang J, Li T, Ni C, Xie J, Zhang JF and Hu XC: MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer. Tumour Biol. 37:7245–7254. 2016. View Article : Google Scholar : PubMed/NCBI
24	Sarkar S, Dubaybo H, Ali S, Goncalves P, Kollepara SL, Sethi S, Philip PA and Li Y: Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am J Cancer Res. 3:465–477. 2013.PubMed/NCBI
25	Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Schmittgen TD and Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
26	Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI